Skip to main content

Table 2 Patients’ Characteristics

From: Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19

Patient

Severe (n = 5)

Critical (n = 10)

p-value

Age (year-old; median (IQR))

73 (57-75)

73 (67-78)

0.8537

Gender (Male: %)

40%

70%

0.3286

BMI (median (IQR))

22.8 (22-24)

25.6 (23-28)

0.4990

First Symptom (%)

 dyspnea

40

20

0.5604

 fever

75

80

0.5604

 cough

20

20

1.0000

 others

40

20

0.5604

Smoking History (%)

75

40

0.6084

Admission day after onset (day; median (IQR))

3 (2-3)

7 (6-8)

0.0160

Complications (%)

 Diabetes

40

60

0.6084

 Renal Dysfunction

20

10

1.0000

 Hemodialysis

20

10

1.0000

 Hypertension

40

40

1.0000

 Hyperlipidemia

0

10

1.0000

 Hyperuricemia

0

20

0.5238

 Cardiovascular Disease

20

0

0.6084

 Respiratory Disease

75

20

0.2507

 Cancer

20

10

1.0000

 Collagen Disease

20

0

0.3333

 Thrombotic disease

0

0

1.0000

 others

2

0

0.0952

APACHE II Score (pts; median (IQR)

5 (5-8)

5 (5-10)

0.2313

  1. *Mann-Whitney U test or Fisher’s exact test; IQR interquartile range, BMI Body Mass Index